Oncology Hematology West (Omaha) - USOR — Omaha, Nebraska

Oncology Hematology West (Omaha) - USOR is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Oncology Hematology West (Omaha) - USOR has participated in 1 clinical trials.

Therapeutic areas: Relapsed and/or Refractory Multiple Myeloma (RRMM).

Sponsors: Takeda.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Hematology West (Omaha) - USOR?

Oncology Hematology West (Omaha) - USOR has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Hematology West (Omaha) - USOR conducted?

Oncology Hematology West (Omaha) - USOR has 1 clinical trials on record. Their work covers Relapsed and/or Refractory Multiple Myeloma (RRMM).

Is Oncology Hematology West (Omaha) - USOR accredited by Crixeo Health?

Oncology Hematology West (Omaha) - USOR has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Hematology West (Omaha) - USOR?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.